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Abstract Neuroticism has been linked to a functional
polymorphism inthe serotonin transportergene (5-HTTLPR),
with short-allele carriers being overrepresented among high-
scorersonneuroticism.Studiesevaluatingneuroticism-related
personality traits in relation to the 5-HTTLPR polymorphism
among patients with premenstrual dysphoric disorder
(PMDD) and are lacking. The primary aim of this study
was to evaluate the relationship between PMDD and
neuroticism-related personality traits, and secondly, to
relate the personality trait scores of PMDD patients to
experienced symptom severity and to the 5-HTTLPR
short allele. Thirty PMDD patients and 55 asymptomatic
healthy controls were included in the study. The Swedish
Universities Scale of Personality was used to evaluate
personality traits. Genotype analyses were available in 27
PMDD patients and 18 healthy controls. Women with
PMDD displayed higher levels of neuroticism-related
personality traits (psychic trait anxiety, somatic trait
anxiety, embitterment, stress susceptibility and mistrust)
than healthy controls, and these effects were most
prominent in women with more severe luteal phase
symptoms. Furthermore, PMDD patients with at least one
copy of the short allele of the 5-HTTLPR polymorphism
scored higher on psychic trait anxiety and lack of assertive-
ness than PMDD patients who were homozygous for the long
allele. PMDD patients who suffer from more severe luteal
phase symptoms also display increased scores of neuroticism-
related personality traits in comparison with healthy controls.
Within the group of PMDD patients, differences in certain
personality trait scores are associated with the short allele of
the 5-HTTLPR polymorphism.
Keywords Personality.Neuroticism.Premenstrual
dysphoric disorder.Swedish universities scale of
personality.5-HTTPLPR
Introduction
The premenstrual dysphoric disorder (PMDD) is character-
ized by a recurrent cluster of physical and negative mood
symptoms during the luteal phase of the menstrual cycle.
Although PMDD is generally regarded as an endocrine
disorder due to its relation to ovulatory menstrual cycles
and progesterone production during the luteal phase
(Segebladh et al. 2009; Sundstrom et al. 1999), mounting
evidence also indicates that personality, psychosocial, and
genetic factors may be important contributors to the
syndrome (Ross and Steiner 2003).
Personality traits are characteristic ways of thinking,
feeling, and behaving. Once adulthood is reached, personality
traits are fairly stable throughout life, and some studies
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al. 2005; Hampson and Goldberg 2006). Neuroticism for
example, defined as an enhanced tendency of experiencing
negative emotions such as stress, anxiety and anger, is a
stable, heritable personality factor (Lesch et al. 1996)w i t h
approximately 50% of the variance accounted for by genetic
factors (Canli 2008; Kendler et al. 2006).
The serotonin transporter (5-HTT) is an integral
membrane protein which transports the neurotransmitter
serotonin from the synaptic cleft into pre-synaptic
neurons. A gene-linked polymorphic region (5-HTTLPR)
located upstream the 5-HTT transcriptional coding
sequence has been reported. The polymorphism consists
of insertion or deletion of 43 bp repeated elements which
create a short (14 repeat units) or a long (16 repeat units)
allele with different transcriptional activities. The short
allele has been associated with lower 5-HTTLPR
expression levels, resulting in lower serotonin uptake
activity compared with the long allele (Heils et al. 1996).
In the adult brain, the phenotypic expression of the 5-
HTTLPR variants seems to be disappeared, suggesting that
the gene variants mainly may regulate fetal development of
the serotonergic system and other systems in the CNS
(Nordquist and Oreland 2010).
Neuroticism has been linked to the functional polymor-
phism in the 5-HTTLPR, with the short-allele carriers being
overrepresented among high-scorers on neuroticism (Canli
and Lesch 2007; Munafo et al. 2006), but non-significant
associations have also been reported (Samochowiec et al.
2004). Studies that do not show correlations between
neuroticism and 5-HTTLPR are, however, typically based
on healthy participants. In populations with major depres-
sion or seasonal affective depression, associations between
5-HTTLPR and neuroticism are more commonly reported
(Munafo et al. 2006; Praschak-Rieder et al. 2002).
The high expressing variant (L/L) has been associated
with psychiatric morbidities such as melancholic depression
(Willeit et al. 2003) and postpartum depression (Sanjuan et
al. 2008) but also to depressive response to tryptophan
depletion (Moreno et al. 2002). Taken together, these
studies suggest that being homozygous for either the low
or high activity allele might increase sensitivity for the
development of mood disorders as compared to being
heterozygous. This notion is further supported by studies on
affective responses to tryptophan depletion, suggesting that
the main effects of 5-HTTLPR polymorphisms on behavior
may be present in the homozygous allele-groups, especially
in female populations (Brummett et al. 2008; Walderhaug et
al. 2007).
The primary aim of this study was to evaluate the
relationship between PMDD and personality traits, and
secondly, to relate the personality trait scores of PMDD
patients to experienced symptom severity and to the 5-
HTTLPR short allele. We hypothesized that women with
PMDD would display increased scores on the
neuroticism-related personality traits in comparison with
control subjects. Furthermore, it was hypothesized that
more symptomatic PMDD patients and 5-HTTLPR short-
allele carriers would display increased scores on the
neuroticism-related personality traits in comparison with
control subjects and possibly also in comparison with
less symptomatic PMDD patients.
Materials and methods
Study population
Thirty PMDD patients and 55 asymptomatic healthy
controls were included in the study. Patients were recruited
among women seeking help for premenstrual symptoms at
the out-patient ward of the Department of Obstetrics and
Gynecology, Uppsala University Hospital and from news-
paper advertisement.
Included patients met the criteria for PMDD, defined in
the Diagnostic and Statistical Manual of Mental Disorders,
fourth edition (DSM-IV, 1994). The diagnosis was based on
daily, prospective symptom ratings on the cyclicity diag-
noser (CD) scale during two cycles prior to inclusion
(Sundstrom et al. 1999). The CD scale consists of nine
negative mood parameters (depression, decreased interest in
usual activities, fatigue, irritability, tension, mood swings,
affective lability, difficulties in concentrating and sleep
disturbances), two positive mood parameters (cheerfulness
and energy), and four somatic symptoms (food cravings,
swelling, breast tenderness, and menstrual bleeding). In
addition, the CD scale contains a score for measuring
every-day social functioning and work performance. The
CD scale is a Likert scale ranging from 0–8, with 0
representing a complete absence of a particular symptom,
and 8 reflecting the maximal severity of the symptom.
Patients were considered to have PMDD if they displayed a
100% increase in the mean ratings of at least five negative
symptoms (or a 50% decrease in positive symptoms) during
seven premenstrual days compared to seven mid-follicular
days, associated with a clinically significant social and
occupational impairment. The threshold for impact on daily
life was set at a score≥4 for more than two days during the
luteal phase (indicating that subjects avoided social inter-
action during these days). To be included, patients also had
to display at least one week of sparse symptoms (scores less
than two) in the mid-follicular phase.
Asymptomatic controls were physically healthy women
with regular menstrual cycles and no self-report of
premenstrual symptoms. Control subjects displayed no
significant cyclicity in mental symptoms between the
418 M. Gingnell et al.follicular and luteal phases on the CD scale during two
consecutive cycles.
The exclusion criteria for both patients and controls were
ongoing treatment with any hormonal compounds, treat-
ment within the last three months with benzodiazepines or
other psychotropic drugs including selective serotonin
reuptake inhibitors (SSRIs) and presence of any ongoing
psychiatric disorder. The presence of psychiatric disorders
was evaluated using a structured psychiatric interview, the
Swedish version of Mini International Neuropsychiatry
Interview (MINI), based on DSM-IV and ICD-10 (Sheehan
et al. 1998).
All women gave written informed consent prior to
inclusion in the study. The study procedures were in
accordance with ethical standards for human experimenta-
tion, and the Independent Research Ethics Committee at
Uppsala University approved the study.
Personality assessment
Personality assessments were made in the follicular phase.
The Swedish universities Scales of Personality (SSP) is a
self-rating questionnaire, based on the Karolinska Person-
ality Scales (KSP) (Schalling et al. 1987). Compared to
KSP, SSP has a reduced number of items and an improved
psychometric quality with better face validity, higher
internal consistency and better response differentiation
(Gustavsson et al. 2000). The SSP contains 91 items and
the participants rated the items on a scale from 1 to 4,
where 1 equals “does not apply at all” and 4 equals “applies
completely”. The items form 13 scales (Table 1). Following
factor analysis, these scales are usually grouped into three
major factors: Neuroticism-related traits (Somatic Trait
Anxiety, Psychic Trait Anxiety, Stress Susceptibility, Lack
of Assertiveness, Embitterment, Mistrust), Aggressiveness
(Trait Irritability, Verbal Trait Aggression, Physical Trait
Aggression, inversed value of Social Desirability)a n d
Extraversion (Impulsiveness, Adventure Seeking, inversed
value of Detachment) (Gustavsson et al. 2000).
For each scale, the SSP scores are transformed into
normative, age-adjusted T scores with means of 50 and
standard deviations of 10 based on a Swedish gender-
stratified non-patient sample (Gustavsson et al. 2000).
5-HTTLPR polymorphism genotype analysis
Blood samples for genotype analyses were available in 27
PMDD patients and 18 healthy controls.
The 5-HTTLPR gene promoter VNTR polymorphism
was amplified from 30 ng genomic DNA using the primer
sequences: forward 5′-AAC ATG CTC ATT TAA GAA
GTG GAA C-3′ and reverse 5′-XCTAGA GGG ACT GAG
CTG GAC AAC-3′. The reverse primer was labeled with
the fluorescent dye 5′-hex.
PCR was performed in a 10-µl reaction mixture containing
30 ng DNA; 1.0 mM PCR Buffer10×, 1.5 mM MgCl2,
0.2 μM dNTPs; 7%DMSO; 0.8 μM of two primers and
0.5 U Fast Start Taq DNA polymerase (Roche Diagnostics,
Germany). The PCR reactions were performed on a
GeneAmp 9700 (Applied Biosystems) at the following
profile: starting at 94°C for 4 min, followed by 35 cycles
of denaturation at 94°C for 45 s, annealing at 61°C for 1 min
and elongation at 72°C for 90 s , with final extension at 72°C
for 7 min. The PCR products were analyzed by capillary
electrophoresis ABI PRISM@3700 DNA Analyzer (Applied
Biosystem, USA) and alleles size were determined manually
checking on chromatograms using Gene Marker1.5® AFLP/
Genotyping software (SoftGenetics LLC®2004. State
College, PA, USA). As control material, one third of
the sample has been analyzed twice. Errors and incon-
sistencies have been identified and the genotype analysis
was carried out a second time and the PCR products
were resolved by electrophoresis on a 2% agarose gel.
The gel was run 1 h at 120 V and visualized under UV
light. Buffer used as a running buffer was 0.5× Tris–
EDTA-Buffer (TEB) and sizes were determined by
comparison with a 100 bp DNA sequencing ladder.
Statistical analyses
The study had an 80% power to detect a mean difference of
5.0 T scores (equal to half a standard deviation) between
PMDD patients (n=30) Control subjects (n=55) p value
Age 33.2±8.9 26.2±4.5 0.001
Height 168±13 168±6 ns
Weight 64.0±13.4 61.6±10.3 ns
Caucasian origin 28 (93.3%) 55 (100.0%) ns
College/university education 20 (66.7%) 37 (67.3%) ns
Married/cohabiting 16 (53.3%) 18 (32.7%) 0.05
Parous subjects 14 (46.7%) 5 (9.1%) 0.001
Smokers 1 (3.3%) 1 (1.8%) ns
Table 1 Demographic variables
and physical characteristics of
the PMDD patients and the
control subjects
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8.0. Continuous variables were compared using indepen-
dent t tests and are presented as mean ± SD. Skewed data
was log-transformed prior to analyses. For evaluation of the
influence of symptom severity on the personality trait
scores one-way ANOVA followed by Tukey’s post hoc
tests was used. Analyses of differences in allele frequency
were performed using chi-square.
Because of the sociodemographic differences between
PMDD patients and control subjects, the personality trait
scores were also compared between groups by multivariate
linear regression with adjustment for parity and civil status.
To enable comparison of PMDD symptom severity
between individuals, a method developed by Wang and
co-workers was used (Wang et al. 1996) in which the
number of expressed negative mood symptoms per day
during the premenstrual period defines high- and low-
severity PMDD patients. The CD-scale ratings of the first
diagnostic cycle were used and the total number of days
with expressed symptoms (symptom score≥2) in the
10-day premenstrual period was counted for each of the
four core symptoms of PMDD (irritability, depression,
anxiety, and mood swings). A day with scores for negative
s y m p t o m sr a n g i n gb e t w e e n0a n d1w a sd e f i n e da s
symptom-free. This procedure resulted in a scale of
symptom severity ranging from 0 to 40. Based on a median
split (27.5), the PMDD patients were divided into two
equally large groups, a high-severity group (n=15) and a
low-severity group (n=15).
Based on prior research (Munafo et al. 2006), analyses of
the 5-HTTLPR genotype influence on personality trait scores
in PMDD patients were made by comparing short-allele
carriers (S/S and S/L) with homozygous carriers of the long
allele (L/L). For further analyses on 5-HTTLPR genotype,
PMDD patients and healthy controls were grouped as
homozygotes (S/S and L/L) and heterozygotes (S/L).
All statistical analyses were performed with SPSS 15.0. A
two-sided p value less than 0.05 was considered significant.
Results
Demographic factors
Thecontrolsubjectswereslightlyyounger,hadfewerchildren
a n dw e r ea l s ol e s sl i k e l yt ob ec o h a b i t i n g / m a r r i e dt h a nt h e
PMDD patients. Otherwise, there were no significant socio-
economic differences between groups (Table 1).
Symptom severity
The high-severity group did not differ from the low-severity
group regarding summarized negative mood scores on the
CD scale (i.e. symptom scores of depression, anxiety, mood
swings, and irritability) during the follicular phase of the
menstrual cycle but displayed higher summarized negative
mood scores in the luteal phase (group × phase interaction
F(1,28)=43.46; p<0.001).
Personality traits
PMDD patients scored significantly higher on somatic trait
anxiety, psychic trait anxiety, embitterment, trait irritability,
mistrust, and detachment compared to healthy control
subjects (Table 2). Following adjustment for parity and
civil status, PMDD patients also displayed increased scores
for stress susceptibility and decreased scores for social
desirability in comparison with control subjects (Table 2).
The differences in personality trait scores between PMDD
patients and healthy controls were mainly driven by most
symptomatic PMDD patients. When high-severity and low-
severity PMDD patients were evaluated separately in
comparison to control subjects, it was primarily the high-
severity PMDD patients who displayed significant
increases in personality trait scores in comparison with the
control subjects. High-severity PMDD patients had higher
scores on somatic trait anxiety, psychic trait anxiety,
embitterment and mistrust as compared to control subjects
(Table 3), whereas low-severity PMDD patients only scored
higher on the detachment scale than control subjects.
Following adjustment for parity and civil status, high-
severity PMDD patients also displayed higher scores for
stress susceptibility and trait irritability in comparison with
control subjects and low-severity PMDD patients also
displayed higher scores of mistrust (Table 3). However,
no differences between high- and low-severity PMDD
patients were detected.
5-HTTLPR polymorphism genotype
5-HTTLPR genotype was completed in 27 PMDD patients
and 18 control subjects. Allele frequencies fell within
expected ranges, based on multiple published reports for
Caucasians. For the healthy controls, the frequency of the
long allele was 0.56 and of the short allele was 0.44,
resulting in Hardy–Weinberg equilibrium (HWE; x
2=2.21;
p=0.14). Corresponding allele frequencies for PMDD
patients were 0.59 of the long allele and 0.41 for the short
allele with HWE (x
2=1.47; p=0.23).
There was a trend that homozygous allele carriers (S/S
and L/L) were more common among PMDD patients (p<
0.051). Ten (37.0%) PMDD patients were heterozygotes
and 17 (63.0%) were homozygotes (S/S, 6 (22.2%); L/L, 11
(40.7%)), whereas the corresponding figures in control
subjects were 12 (66.7%) heterozygotes and six (33.3%)
homozygotes (S/S, 2 (11.1%); L/L, 4 (22.2%)).
420 M. Gingnell et al.Within the PMDD patients, short-allele carriers dis-
played higher scores on psychic trait anxiety (presence of
short 54.0±6.9 vs. L/L 46.0±10.8, p<0.05) and lack of
assertiveness (presence of short 53.0±6.8 vs. L/L 42.5±9.8,
p<0.01). Because of the low frequency of homozygous
carriers of the long allele among control subjects, compar-
isons of personality trait scores were not performed with
this group.
Discussion
The main finding of the present study was that PMDD
patients displayed increased scores of psychic trait anxiety,
somatic trait anxiety, embitterment, stress susceptibility, and
mistrust compared to control subjects. These traits, together
with lack of assertiveness, are considered to belong to the
domain of neuroticism-related personality traits in the SSP
Table 3 Mean ± standard deviation of personality trait Tscores on the Swedish universities scale of personality for high- and low-severity PMDD
patients and control subjects
SSP subscales PMDD high-severity (n=15) PMDD low-severity (n=15) Control subjects (n=55)
Somatic trait anxiety 55.1±9.4
a 49.5±7.8 45.7±6.8
Psychic trait anxiety 52.1±9.9
b 50.0±8.4 46.5±7.3
Embitterment 51.9±11.0
c 46.3±9.3 44.5±6.7
Stress susceptibility 54.9±12.2
d 52.2±9.9 48.8±10.3
Mistrust (logarithmic) 52.4±12.2
a 48.5±9.2
d 42.2±8.4
Lack of assertiveness 49.2±11.0 49.0±8.5 48.9±8.0
Trait irritability 54.2±11.8
d 53.0±13.5 47.5±10.2
Verbal trait aggression 50.8±9.2 47.5±11.4 47.6±8.7
Physical trait aggression (logarithmic) 45.6±8.7 46.1±12.0 41.8±7.1
Social desirability 48.2±8.7 51.0±5.6 51.0±8.8
Impulsiveness 52.0±7.2 48.9±9.2 47.0±8.2
Adventure seeking 49.6±10.9 49.2±9.4 50.2±8.0
Detachment 48.8±9.3 50.4±6.2
b 44.8±8.0
There were no significant differences in personality trait scores between high- and low-severity PMDD patients
aSignificantly different from control subjects, p<0.001, one-way ANOVA with post hoc Tukey HSD
bSignificantly different from control subjects, p<0.05, one-way ANOVA with post hoc Tukey HSD
cSignificantly different from control subjects, p<0.01, one-way ANOVA with post hoc Tukey HSD
dSignificantly different from controls, p<0.05–0.01, linear regression with adjustment for parity and civil status
Table 2 Mean ± standard deviation of personality trait T scores on the Swedish universities scale of personality for PMDD patients and control
subjects
SSP subscales PMDD patients (n=30) Control subjects (n=55) Unadjusted p value Adjusted p value
a
Somatic trait anxiety 52.3±9.0 45.7±6.8 0.001 0.001
Psychic trait anxiety 51.0±9.1 46.5±7.3 0.014 0.003
Embitterment 49.1±10.4 44.5±6.7 0.034 0.002
Stress susceptibility 53.5±11.0 48.8±10.3 0.051 0.001
Mistrust (logarithmic) 50.5±10.8 42.2±8.4 0.001 0.001
Lack of assertiveness 49.1±9.7 48.9±8.0 0.91 0.35
Trait irritability 53.6±12.4 47.5±10.2 0.016 0.005
Verbal trait aggression 49.2±10.3 47.6±8.7 0.48 0.075
Physical trait aggression (logarithmic) 45.8±10.3 41.8±7.1 0.073 0.077
Social desirability 49.6±7.3 51.0±8.8 0.48 0.022
Impulsiveness 50.4±9.9 47.0±8.2 0.09 0.09
Adventure seeking 49.4±10.0 50.2±8.0 0.69 0.86
Detachment 49.6±7.8 44.8±8.0 0.009 0.01
aAdjusted for parity and civil status
Neuroticism-related personality traits 421(Gustavsson et al. 2000). Furthermore, our results indicated
that the differences in personality trait scores between
PMDD patients and control subjects were mainly driven by
the most symptomatic PMDD patients, as only one of the
neuroticism-related personality trait scores was different
between low-severity patients and control subjects. These
findings could implicate that certain personality traits are
related to, not only the development of PMDD, but also the
severity of the disorder, a relationship also reported by
Freeman et al. (1995).
Clearly, our findings must been interpreted in the light of
the relatively low power of the study and the fact that no
correction for multiple comparisons was made. Besides the
neuroticism-related personality trait scores, a larger sample
sizecould possiblyhavebeenabletofinddifferencesbetween
PMDD patients and controls in the aggressiveness scores as
well. Furthermore, the non-significant differences in person-
ality trait scores between high- and low-severity PMDD
patients may also reflect the relatively modest sample size.
Research in PMDD and personality is limited and many
studies have relied on retrospective ratings by participants
for the premenstrual syndrome/PMDD diagnosis, a method
that not only gives a general exaggeration of reported
symptoms, but also has been shown to especially bias
individuals with neuroticism-related personality traits to
overestimate their symptoms (Taylor et al. 1991). However,
more recent studies, based on prospective ratings, have
indicated that certain personality traits can be associated to
PMDD. Critchlow et al. (2001) found a higher degree of
obsessive–compulsive traits in PMDD patients than in
healthy controls, and Freeman et al. (1995) reported that
PMDD patients had increased scores on harm avoidance,
novelty seeking, and slightly higher scores on reward
dependence in comparison to a normal population. The
differences in personality trait scores between the PMDD
patients and the healthy controls in the present study were
small and are thus more likely to reflect variations within
the normal spectra rather than actual personality disorders.
This would be in line with the study of Critchlow et al.
(2001) who investigated the prevalence of personality
disorders and did not report a higher prevalence in PMDD
patients than in healthy controls.
PMDD patients who carried the short allele for 5-HTTLPR
displayed increased scores of psychic trait anxiety and lack of
assertiveness in comparison with PMDD patients who were
homozygous carriers of the long allele. This finding is in line
with previous research indicating that neurotic personality
traits are related to the short allele of the serotonin transporter
gene (Canli 2008; Lesch et al. 1996). Taken together, genetic
vulnerability factors and associated personality traits may, in
concert or separately, influence symptom severity in PMDD
patients. As both these factors, and especially genetic
vulnerability factors, are associated with major depression
(Enns and Cox 1997; Kendler et al. 2006;R a m k l i n ta n d
Ekselius 2003), our results may also suggest that highly
symptomatic PMDD patients (with elevated neuroticism-
related personality trait scores) may be more prone to
develop major depression. However, whether PMDD
patients with high scores on neuroticism-related personality
traits and/or genetic vulnerability factors are particularly
susceptible for future development of depression remains to
be evaluated in longitudinal studies.
There was a trend that PMDD patients more often were
carriers of the homozygous alleles for 5-HTTLPR than
control subjects. However, because of the limited sample
size and prior negative findings in terms of allelic
distribution profiles in PMDD patients (Magnay et al.
2006), these data need confirmation in larger cohorts before
any interpretations can be made.
In conclusion, the present study indicates that PMDD
patients have higher scores of neuroticism-related traits than
healthy controls and this finding was mainly driven by the
most symptomatic patients. Moreover, PMDD patients who
carried the short allele for 5-HTTLPR displayed increased
scores of psychic trait anxiety and lack of assertiveness in
comparison with PMDD patients who were homozygous
carriers of the long allele. The differences in neuroticism-
related personality traits between PMDD patients and
healthy controls and the differences in personality traits
scores due to variable genetic vulnerability within the
PMDD group might support the fact that the development
and severity of PMDD is related to neurobiological risk
factors and that those risk factors might be similar to the
mechanisms underlying major depression. Clearly, further
studies elucidating the interactions between personality
factors and genetic susceptibility in larger samples of
PMDD patients are warranted.
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